24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Sisram Medical
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
07:29
MSC denies interest in acquiring ZIM
21:50
Full list of Israeli startup M&As in 2025
21:48
Zendesk acquires AI search startup Unleash for tens of millions
21:03
As Intel stumbles, Nvidia emerges as Israel’s anchor tech employer
More stories
Buzz
Most popular
Daily
Weekly
1
Huang declares Israel Nvidia’s “second home” with record-breaking campus investment
2
Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal
3
UAE reportedly behind Elbit’s record $2.3 billion defense deal
4
Palo Alto Networks CEO: “We’re happy Wiz is now part of Google, it gives us more room to operate”
5
Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation
More news
Sisram Medical
5 stories about Sisram Medical
Fosun Whetted Our Appetite, Says Alma Lasers CEO
04.07.19
|
Golan Hazani
Fosun Pharma CEO Yifang Wu and Alma Lasers CEO Lior Dayan gave Calcalist their first joint interview since the Chinese conglomerate acquired the Israeli medical laser company in 2013
Fosun Pharma Inaugurates New Building for Israeli Subsidiary Sisram Medical
26.02.19
|
Golan Hazani
Fosun paid $240 million for a 95% stake in the Israeli cosmetic surgery in 2014, floating it on the Hong Kong Exchange in 2017
Fosun Pharma Subsidiary Sisram Medical Leases 11,000-Square-Meter Building in Caesarea
10.12.18
|
Dotan Levy
The ten-year lease is estimated at $1.7 million (NIS 6.3 million) per year. China’s Fosun Pharma bought Sisram in 2014 for $240 million, renaming it from Alma Lasers
Sisram Stock Price Down on Market Debut
19.09.17
|
Amarelle Wenkert
The Fosun Pharma subsidiary debuted on the Hong Kong Stock Exchange Tuesday
Sisram Medical Seeks to Raise Up To $176 Million in Hong Kong IPO
10.09.17
|
Amarelle Wenkert
On September 5, the Fosun Pharma subsidiary submitted a prospectus to the Hong Kong Stock Exchange